Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunal Nepali

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Medicinal Chemistry|April 10, 2016
Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studiesHarbinder Singh, Mandeep Kumar, Kunal Nepali, et al.
Expert Opinion on Drug Discovery|October 18, 2024
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challengesAnshul Mishra, Amandeep Thakur, Ram Sharma, et al.
European Journal of Medicinal Chemistry|August 17, 2014
Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studiesSahil Sharma, Charanjit Kaur, Abhishek Budhiraja, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2017
Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studiesHarbinder Singh, Jatinder V Singh, Manish K Gupta, et al.
European Journal of Medicinal Chemistry|January 11, 2023
Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effectsKunal Nepali, An-Chih Wu, Wei-Lun Lo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 21, 2025
Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeuticsRam Sharma, Anshul Mishra, Monika Bhardwaj, et al.
International Journal of Pharmaceutics|April 26, 2012
Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomesSarandeep Singh Malhi, Abhishek Budhiraja, Sumit Arora, et al.
Organic and Medicinal Chemistry Letters|March 5, 2013
Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitorsSunil Kumar, Samir Mehndiratta, Kunal Nepali, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 16, 2012
Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studiesVeenu Mangla, Kunal Nepali, Gagandip Singh, et al.
Molecules (Basel, Switzerland)|July 24, 2021
The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF ProductionTai-Ju Hsu, Kunal Nepali, Chi-Hao Tsai, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|April 10, 2016
Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studiesHarbinder Singh, Mandeep Kumar, Kunal Nepali, et al.
Expert Opinion on Drug Discovery|October 18, 2024
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challengesAnshul Mishra, Amandeep Thakur, Ram Sharma, et al.
European Journal of Medicinal Chemistry|August 17, 2014
Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studiesSahil Sharma, Charanjit Kaur, Abhishek Budhiraja, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2017
Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studiesHarbinder Singh, Jatinder V Singh, Manish K Gupta, et al.
European Journal of Medicinal Chemistry|January 11, 2023
Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effectsKunal Nepali, An-Chih Wu, Wei-Lun Lo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|April 21, 2025
Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeuticsRam Sharma, Anshul Mishra, Monika Bhardwaj, et al.
International Journal of Pharmaceutics|April 26, 2012
Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomesSarandeep Singh Malhi, Abhishek Budhiraja, Sumit Arora, et al.
Organic and Medicinal Chemistry Letters|March 5, 2013
Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitorsSunil Kumar, Samir Mehndiratta, Kunal Nepali, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 16, 2012
Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studiesVeenu Mangla, Kunal Nepali, Gagandip Singh, et al.
Molecules (Basel, Switzerland)|July 24, 2021
The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF ProductionTai-Ju Hsu, Kunal Nepali, Chi-Hao Tsai, et al.
Pageof 9